Quick Facts
| Property | Value |
|---|---|
| Category | Mitochondrial Support / Cellular Energy Compound |
| Risk Level | Moderate |
| Administration | IM, SubQ, or IV |
| Typical Frequency | 3–5x Weekly Loading / 1–2x Weekly Maintenance |
| Estimated Half-Life | Rapid Cellular Utilization |
| Primary Research Interest | Cellular Energy / Mitochondrial Support / Recovery |
This material is provided strictly for educational and informational purposes related to peptide research and mitochondrial-support compounds. NAD+ is a biologically active coenzyme involved in cellular energy production, mitochondrial signaling, metabolic regulation, and recovery pathways. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.
1. Reconstitution Guide
- Vial Size: 1000 mg
- Dilutant Type: BAC Water
- Amount of Dilutant Added: 5 mL
- Final Concentration: 200 mg/mL
At this concentration:
• 50 mg = 0.25 mL (25 units)
• 200 mg = 1.00 mL (100 units)
2. Intramuscular Route & Primary Protocol
NAD+ is commonly researched as an intramuscular mitochondrial-support and cellular-energy compound.
- Primary Route: IM Injection
- Typical Delivered Amount: 50–200 mg
- Frequency: Several times weekly
- Loading Cycle: 4–12 weeks at 3–5 administrations weekly
- Maintenance Cycle: Indefinite maintenance dosing 1–2 times weekly
- Special Notes: NAD+ is commonly researched for mitochondrial support, cellular energy production, recovery, cognitive performance, and healthy-aging pathways. Many experimental users report that effects often develop gradually over time, with consistency appearing more important than aggressive high dosing. Because NAD+ administration can produce significant injection discomfort, flushing, nausea, chest tightness, anxiety, or autonomic symptoms — especially with rapid IV infusion — conservative dose escalation is strongly emphasized. Researchers frequently begin with lower doses and slower administration speeds before progressing toward more aggressive protocols.
3. Subcutaneous Protocols
- Common Experimental Range: 25–100 mg daily or several times weekly
- Administration Notes: Many users begin conservatively because SQ injections may sting significantly
4. IV Infusion Protocols
- Common Infusion Range: 250–1000 mg IV infusions
- Typical Infusion Duration: 1–6 hours
- Rapid Infusion Risks: Chest tightness, nausea, flushing, anxiety, abdominal discomfort
5. Summary
NAD+ is an experimental mitochondrial-support compound researched for its potential effects on cellular energy production, recovery, cognitive performance, metabolic support, and healthy-aging pathways.
Research interest in NAD+ commonly centers around mitochondrial resilience, fatigue reduction, neurological support, recovery enhancement, and metabolic optimization.
6. Mechanism of Action
NAD+ functions as a critical coenzyme involved in mitochondrial energy production, cellular metabolism, DNA repair signaling, and oxidative-stress regulation.
- Mitochondrial energy production
- ATP generation support
- Cellular repair signaling
- Metabolic pathway regulation
- Oxidative-stress modulation
- Neurological energy support
The compound is commonly researched for its role in maintaining cellular resilience and metabolic function.
7. Potential Benefits
- Potential energy-production support
- Possible recovery enhancement
- Potential cognitive-support effects
- Possible mitochondrial-support applications
- Potential metabolic resilience support
- Possible healthy-aging pathway support
8. Potential Risks / Side Effects
Moderate
- Injection discomfort or burning
- Flushing
- Nausea
- Chest tightness
- Anxiety or autonomic overstimulation
- Abdominal discomfort
- Headaches
9. Half-Life
NAD+ is rapidly utilized by cellular metabolic pathways and is commonly discussed as having a relatively short circulating duration.
However, downstream mitochondrial and metabolic effects may persist considerably longer than measurable plasma availability.
10. Storage Information
- Store refrigerated before and after reconstitution
- Protect from direct light exposure
- Maintain sterile handling practices during preparation
- Discard solutions showing discoloration or contamination
11. Contraindications / Warnings
- Severe cardiovascular instability
- Pregnancy or breastfeeding
- Known hypersensitivity to peptide compounds
- Use alongside multiple metabolic compounds without supervision
- Significant autonomic sensitivity concerns
12. Research References
- PubMed
- NIH Publications
- Mitochondrial and metabolic literature
- Peer-reviewed aging and cellular-energy journals
CKF Tide Tables 